-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on Pediatric Non-Malignant Hematology Highlights

Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, Clinical Trials, Bleeding and Clotting, bleeding disorders, Sickle Cell Disease, autoimmune disorders, Biological therapies, Antibody Therapy, Anticoagulant Drugs, Access To Care, Clinical Practice (Health Services and Quality), Epidemiology, hemophilia, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Sickle Cell Trait, Non-Biological therapies, Age Inequities, Workforce, Health Outcomes Research, platelet disorders, Aplastic Anemia, Genetic Disorders, Thalassemia, genomics, Health Disparities Research, thromboembolism, Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinopathies, Coagulant Drugs, hematopoiesis, Cultural Sensitivity, Patient-Reported Outcomes, Diseases, thrombocytopenias, Immune Disorders, immunodeficiency, Gene Therapy, Devices, immune mechanism, Pediatric, Disability Inequities, Real World Evidence, thrombotic disorders, Therapies, Immunotherapy, Opioids, immunology, Neonatal, Disparities, Registries, VWD, white blood cell disorders, Infusion, metabolism, Equity, Autoimmune Hemolytic Anemia, Monoclonal Antibody Therapy, Pharmacology, Biological Processes, microbiome, Young Adults, Gender Inequities, Technology and Procedures, gene editing, Implicit Bias, Transfusion, multi-systemic interactions, profiling, Study Population, LGBTQ Inequities, Transplantation, pathogenesis, Racial Inequities, machine learning, Diversity, Equity, and Inclusion (DEI), Racism, Representation, Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.), Socioeconomic Inequities, Newborn Screening, Serologic Tests
Wednesday, December 15, 2021: 5:00 PM-6:00 PM
(VIRTUAL PROGRAM)
Please view the recorded poster presentations prior to attending this virtual session:

The ASH Poster Walk on Pediatric Non-malignant Hematology will review the poster highlights for new and emerging research that you must see in pediatric hematology -- including thrombosis/hemostasis, immune cytopenias, hemoglobinopathies, and other rare hematologic pediatric conditions. Join others interested in pediatric hematology and network with them as well as meeting the authors of these selected abstracts. Learn about where cutting edge research is in this field in 2021; and we hope you leave with exciting research questions (and maybe collaborations) of your own as a result!

The following abstracts will be featured in this session:

The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections, Michele Lambert

Use of Red Blood Cell Phenotypes for Second Line Therapy Selection in Sickle Cell Disease, Celeste Kanne

Evaluating Clinical Outcomes and Potential Prognostic Factors Among 308 Children and Adolescents with Immune Thrombocytopenia (ITP): An 11-Year Retrospective Cohort Study, Xiaopei Zeng

Molecular and Biological Characterization of Transient Antithrombin Deficiency: A New Concept in Congenital Thrombophilia, Maria Eugenia de la Morena-Barrio

The Impact of the “Super Coombs” Test on Patient Management and Outcomes at a Large Tertiary Care Center: A Retrospective Review, Mamie Thant

Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Cardiac Magnetic Resonance Imaging (CMR), Cara Morin

See more of: ASH Poster Walks